Finasteride Tablets

Finasteride is a synthetic 4-azasteroid and a competitive specific inhibitor of type II 5alpha;-reductase. Type II 5alpha;-reductase can metabolize testosterone into dihydrotestosterone in the prostate, liver, and skin. Finasteride has no affinity for androgen receptors. The growth of the prostate and subsequent benign prostatic hyperplasia depend on the conversion of testosterone to dihydrotestosterone in the prostate. Finasteride is suitable for the treatment of benign prostatic hyperplasia. It can significantly reduce circulating and intraprostatic dihydrotestosterone. Within 24 hours of oral finasteride, the concentration of circulating dihydrotestosterone is significantly reduced. With long-term medication, dihydrotestosterone is suppressed, the volume of the prostate is significantly reduced, the maximum urine flow rate is increased, and the overall symptoms and obstructive symptoms are improved.

The main ingredient of this product is finasteride. Its chemical name is N-(1,1-dimethylethyl)-3-oxo(5alpha;,17beta;)-4-azaandrost-1-ene-17-amide. Molecular formula: C23H36N2O2 Molecular weight: 372.55

This product is a film-coated tablet, which appears white after removing the film coating.

1. This product is suitable for the treatment of symptomatic benign prostatic hyperplasia (BPH). Improve symptoms. Reduce the risk of acute urinary retention. Reduce the risk of transurethral resection of the prostate (TURP) and prostatectomy. 2. It is suitable for the treatment of male baldness (androgenic alopecia), which can promote hair growth and prevent further hair loss.

Oral, recommended dose: 5 mg (1 tablet) each time, once a day, can be taken on an empty stomach or with food.

Well tolerated. The most common adverse effects are impotence and reduced ejaculation volume. Occasionally, breast enlargement and tenderness, allergic reactions, etc.

1. People who are allergic to any component of this product. 2. Women and children.

Precautions for children: Forbidden to use in children Precautions for pregnancy and lactation: Forbidden to use in women Precautions for the elderly: No dosage adjustment is required for elderly patients.

No important drug interactions have been found clinically. This product does not seem to significantly affect the drug metabolism enzyme system related to cytochrome P450. In clinical trials, this product was used in combination with angiotensin converting enzyme inhibitors, alpha-blockers, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-COA reductase inhibitors, non-steroidal anti-inflammatory drugs, quinolones and benzodiazepines, and no obvious adverse interactions were found.

Keep away from light and store in sealed container.

5mg

24 months